Money Raised: $45 million
Investors: Oracle, Otsuka, Novartis and Sino Portfolio and other undisclosed investors.
Funding Round: Series F
What is does: Protesus Digital Health is building a new category of products called "digital medicines" that incorporate a tiny ingestible sensor able to wirelessly transmit data on patients' medication-taking behavior and how their bodies react to the medication.
Total Funds Raised: at least $152.1 million
Location: Redwood City, California
CEO: Andrew Thompson
Source: Rock Health Report, Proteus Digital Health and SEC Filings